Edwards Lifesciences Return on Tangible Equity 2010-2024 | EW

Current and historical return on tangible equity values for Edwards Lifesciences (EW) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Edwards Lifesciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-06-30 $1.47B $5.94B 27.29%
2024-03-31 $1.41B $5.49B 27.76%
2023-12-31 $1.40B $5.17B 29.24%
2023-09-30 $1.43B $5.00B 31.14%
2023-06-30 $1.39B $4.72B 30.59%
2023-03-31 $1.49B $4.31B 33.24%
2022-12-31 $1.52B $4.36B 33.89%
2022-09-30 $1.46B $4.79B 32.51%
2022-06-30 $1.46B $4.46B 33.83%
2022-03-31 $1.54B $4.36B 37.58%
2021-12-31 $1.50B $4.34B 39.60%
2021-09-30 $1.48B $4.05B 42.51%
2021-06-30 $1.46B $3.64B 46.56%
2021-03-31 $0.85B $3.16B 30.20%
2020-12-31 $0.82B $3.07B 31.34%
2020-09-30 $0.79B $2.71B 31.48%
2020-06-30 $0.74B $2.34B 30.81%
2020-03-31 $1.11B $2.40B 47.85%
2019-12-31 $1.05B $2.64B 47.24%
2019-09-30 $0.77B $2.28B 39.16%
2019-06-30 $0.73B $1.94B 39.19%
2019-03-31 $0.77B $2.00B 43.53%
2018-12-31 $0.72B $1.69B 43.45%
2018-09-30 $0.71B $1.77B 45.03%
2018-06-30 $0.66B $1.58B 41.52%
2018-03-31 $0.56B $1.62B 35.47%
2017-12-31 $0.58B $1.36B 38.29%
2017-09-30 $0.75B $1.77B 45.73%
2017-06-30 $0.72B $1.57B 43.37%
2017-03-31 $0.66B $1.40B 39.39%
2016-12-31 $0.57B $1.79B 33.82%
2016-09-30 $0.55B $1.86B 33.34%
2016-06-30 $0.53B $1.63B 33.27%
2016-03-31 $0.52B $1.47B 31.09%
2015-12-31 $0.50B $1.67B 28.34%
2015-09-30 $0.46B $1.59B 26.05%
2015-06-30 $0.44B $1.90B 24.60%
2015-03-31 $0.87B $1.83B 51.74%
2014-12-31 $0.81B $1.79B 55.40%
2014-09-30 $0.78B $1.64B 59.88%
2014-06-30 $0.76B $1.50B 66.84%
2014-03-31 $0.31B $0.92B 29.22%
2013-12-31 $0.39B $1.13B 35.39%
2013-09-30 $0.40B $0.99B 37.50%
2013-06-30 $0.40B $1.13B 35.63%
2013-03-31 $0.37B $1.15B 34.23%
2012-12-31 $0.29B $1.03B 28.03%
2012-09-30 $0.27B $1.13B 26.20%
2012-06-30 $0.25B $1.02B 25.74%
2012-03-31 $0.24B $0.98B 25.10%
2011-12-31 $0.24B $0.92B 25.28%
2011-09-30 $0.24B $0.94B 25.46%
2011-06-30 $0.24B $0.96B 25.63%
2011-03-31 $0.24B $0.93B 27.38%
2010-12-31 $0.22B $0.93B 26.92%
2010-09-30 $0.20B $0.85B 26.20%
2010-06-30 $0.23B $0.73B 31.22%
2010-03-31 $0.22B $0.75B 31.27%
2009-12-31 $0.23B $0.76B 35.94%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $40.042B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.467B 25.92
Intuitive Surgical (ISRG) United States $180.733B 94.49
Alcon (ALC) Switzerland $45.462B 32.00
IQVIA Holdings (IQV) United States $38.149B 21.02
IDEXX Laboratories (IDXX) United States $33.943B 39.97
DexCom (DXCM) United States $27.225B 41.00
Waters (WAT) United States $22.999B 34.01
STERIS (STE) Ireland $22.270B 25.99
SONOVA HOLDING (SONVY) Switzerland $21.961B 0.00
Hologic (HOLX) United States $19.446B 20.52
Fresenius Medical Care AG KGaA (FMS) Germany $11.766B 13.19
Sysmex ADR (SSMXY) Japan $11.599B 36.37
Globus Medical (GMED) United States $10.118B 28.30
Teleflex (TFX) United States $9.629B 15.36
Penumbra (PEN) United States $8.808B 86.28
Masimo (MASI) United States $7.841B 41.99
Glaukos (GKOS) United States $7.219B 0.00
PROCEPT BioRobotics (PRCT) United States $5.065B 0.00
Integer Holdings (ITGR) United States $4.244B 24.06
Inari Medical (NARI) United States $2.865B 0.00
TransMedics (TMDX) United States $2.852B 90.39
Veracyte (VCYT) United States $2.687B 166.57
LivaNova (LIVN) United Kingdom $2.661B 15.36
Nihon Kohden (NHNKY) Japan $2.561B 15.94
Elekta AB (EKTAY) Sweden $2.323B 18.92
Tandem Diabetes Care (TNDM) United States $2.151B 0.00
RxSight (RXST) United States $1.896B 0.00
Integra LifeSciences Holdings (IART) United States $1.871B 9.73
Alphatec Holdings (ATEC) United States $1.185B 0.00
Artivion (AORT) United States $1.150B 105.61
OPKO Health (OPK) United States $1.032B 0.00
Pulse Biosciences (PLSE) United States $0.934B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.883B 15.01
OrthoPediatrics (KIDS) United States $0.696B 0.00
Pacific Biosciences Of California (PACB) United States $0.684B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.662B 0.00
Mesa Laboratories (MLAB) United States $0.641B 16.18
IRadimed (IRMD) United States $0.626B 33.81
AxoGen (AXGN) United States $0.622B 0.00
SiBone (SIBN) United States $0.568B 0.00
Paragon 28 (FNA) United States $0.506B 0.00
CVRx (CVRX) United States $0.365B 0.00
Tactile Systems Technology (TCMD) United States $0.359B 19.62
ClearPoint Neuro (CLPT) United States $0.352B 0.00
Treace Medical Concepts (TMCI) United States $0.338B 0.00
Delcath Systems (DCTH) United States $0.299B 0.00
AngioDynamics (ANGO) United States $0.274B 0.00
Sight Sciences (SGHT) United States $0.234B 0.00
Inogen (INGN) United States $0.214B 0.00
Semler Scientific (SMLR) United States $0.210B 14.62
Nevro (NVRO) United States $0.199B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Accuray (ARAY) United States $0.180B 0.00
Atossa Genetics (ATOS) United States $0.177B 0.00
Alpha Tau Medical (DRTS) Israel $0.156B 0.00
KORU Medical Systems (KRMD) United States $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.122B 0.00
908 Devices (MASS) United States $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.104B 15.51
EDAP TMS S.A (EDAP) France $0.100B 0.00
WORK Medical Technology Group (WOK) China $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Precision Optics (POCI) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
NexGel (NXGL) United States $0.019B 0.00
Baird Medical Investment Holdings (BDMD) $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
T2 Biosystems (TTOO) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00